SEHK:2228Life Sciences
XtalPi Holdings (SEHK:2228) Is Up 6.6% After Eli Lilly Endorses Ailux AI Platform Partnership Has The Bull Case Changed?
On November 5, 2025, Ailux announced a platform-based collaboration with Eli Lilly to expedite the discovery and development of bispecific antibodies using Ailux’s AI-powered engineering platform, with the deal including upfront and near-term payments in the double-digit millions and potential milestones up to US$345 million.
This partnership highlights the value of Ailux’s AI technology in drug discovery and represents a significant validation from an established pharmaceutical...